43 results
DEFR14A
RYTM
Rhythm Pharmaceuticals, Inc.
7 Aug 24
Revised proxy
6:00am
the leadership and development of executive women, and she continues to serve as its principal. Ms. Tetrault began her career as a lawyer in private healthcare
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals, Inc.
6 Aug 24
Rhythm Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Update
7:00am
%), and headache (26%).
USE IN SPECIFIC POPULATIONS
Pregnancy
There are no data from the use of setmelanotide in pregnant women. Animal studies do not indicate
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals, Inc.
7 May 24
Rhythm Pharmaceuticals Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update
7:10am
There are no data from the use of setmelanotide in pregnant women. Animal studies do not indicate direct harmful effects with respect to reproductive toxicity
8-K
EX-99.1
yrxxtcakq65vn3t4
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
8-K
EX-99.1
eaw273ps6zz3jh6vjp
7 Nov 23
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
vq9pt5 v3t5yg764h
1 Aug 23
Rhythm Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business
7:05am
8-K
EX-99.1
yfzfuf w2fgqdx47ip42
2 May 23
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
qyzvp3vc9x3i nbqc
8 Nov 22
Rhythm Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Update
7:03am